Applications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells

Area of Science:

• Oncology
• Artificial Intelligence
• Biomedical Data Integration

Background:

• B-cell non-Hodgkin lymphomas (B-NHLs) present challenges in diagnosis, prognosis, and treatment due to tumor heterogeneity and complex tumor ecosystems.
• Personalized treatment strategies are crucial for improving patient outcomes in B-NHLs.

Purpose of the Study:

• To explore the potential of multimodal artificial intelligence (AI) in understanding B-cell non-Hodgkin lymphomas (B-NHLs).
• To review multimodal AI frameworks, applications in precision medicine, and specific uses in B-NHLs.

Main Methods:

• Review of multimodal AI frameworks and their applications in precision medicine.
• Exploration of multimodal AI's utility in analyzing B-NHL complexity, identifying immune biomarkers, and optimizing therapy.

Main Results:

• Multimodal AI can synthesize diverse biomedical data (clinical, imaging, pathology, omics) to provide a comprehensive view of tumors.
• Examples of multimodal AI applications in B-NHLs include ecosystem analysis, biomarker identification, and therapy optimization.

Conclusions:

• Multimodal AI offers a powerful approach to enhance the understanding and personalized treatment of B-cell non-Hodgkin lymphomas.
• Addressing limitations and future directions is essential for advancing multimodal AI in clinical practice and healthcare.